Capital Raising

Blank-check SPAC priced a $100M IPO of 10,000,000 units at $10.00 each, to be listed on the Nasdaq Global Market.

Leadership read: Harbour Island Acquisition Corp. I's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.

curated · 2026-10-13 · context →

Q-Gold (QGOLD) announced filing of a final short form base shelf prospectus, a registration that enables future equity or debt raises over a multi-year period.

Leadership read: Fresh capital is a hiring signal before it is anything else. For Q-Gold Resources Ltd., a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Q-Gold Resources Ltd. hires first across Americas; that is where the capital is really pointed.

curated · 2026-10-13 · context →

Albert Invent raised $55M in Series B funding led by TCV to expand its AI platform for chemistry and materials R&D. Existing investors Coatue, J.P. Morgan Growth Equity Partners, Index Ventures and Applied Ventures also participated, alongside new investors Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital and Legion VC.

Leadership read: Albert Invent's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.

curated · 2026-10-13 · context →

A $25 million gift from the Smilow Foundation will establish the Smilow Center for Precision Therapeutics at Penn Medicine.

Leadership read: Fresh capital is a hiring signal before it is anything else. For Penn Medicine, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Penn Medicine hires first across Americas; that is where the capital is really pointed.

curated · 2026-10-13 · context →

Albert, an Oakland-based chemistry-native AI company, raised $55M in Series B funding led by TCV with Truffle Capital, plus new and existing investors including Coatue, J.P. Morgan Growth Equity Partners, Index Ventures and Applied Ventures.

Leadership read: Albert's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.

curated · 2026-10-13 · context →

Auckland open banking fintech Qippay has raised NZ$5 million (about A$4m), with Australian fund All Roads Wholesale Fund taking a 25% stake in parent Qippay Group. The deal is expected to complete later.

Leadership read: Qippay Group's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Oceania.

curated · 2026-10-12 · context →

Stonepeak is preparing meetings for a roughly $150m listed credit fund with a six-year term, which would be the first ASX-listed fund of its kind.

Leadership read: Stonepeak's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Oceania.

curated · 2026-10-12 · context →

Kalamazoo Resources completed part of a $10m placement, including a $7.84m subscription by Muqasab SPV at 18c per share for a 9.9% stake, to fund its pre-feasibility study on the 1.44Moz Ashburton gold project.

Leadership read: Fresh capital is a hiring signal before it is anything else. For Kalamazoo Resources (ASX:KZR), a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Kalamazoo Resources (ASX:KZR) hires first across Oceania; that is where the capital is really pointed.

curated · 2026-10-12 · context →

Genesis Energy (ASX:GNE) is raising equity through a dividend reinvestment plan share issue, a modest capital raise by an energy utility.

Leadership read: Fresh capital is a hiring signal before it is anything else. For Genesis Energy, a raise in Energy funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Genesis Energy hires first across Oceania; that is where the capital is really pointed.

curated · 2026-10-12 · context →

Tsinghua-linked space-robotics startup Xianyin closed a Series A round with backing from Alibaba and China Mobile, both strategic investors.

Leadership read: Fresh capital is a hiring signal before it is anything else. For Xianyin, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Xianyin hires first across Asia; that is where the capital is really pointed.

curated · 2026-10-12 · context →

Genting, the leisure group controlled by Lim Kok Thay, announced a renounceable rights issue to raise about 1.25 billion ringgit (US$306 million), priced at a 25-30% discount. The shares fell as much as 17%, the steepest drop since 1998.

Leadership read: Genting's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Asia.

curated · 2026-10-12 · context →

Korean AI-for-biotech startup GAIA-BT is actively running a Series A round to fund technology upgrades and business expansion, after an earlier seed round. It has also begun paid PoC revenue with Cyron Therapeutics and holds MOUs and LOIs with domestic and foreign institutions.

Leadership read: Fresh capital is a hiring signal before it is anything else. For GAIA-BT (가이아비티), a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where GAIA-BT (가이아비티) hires first across Asia; that is where the capital is really pointed.

curated · 2026-10-12 · context →